Twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn therapy for newly diagnosed type 1 diabetes

被引：0
|
作者：
Al Shamsi, Aisha Mohammed [1 ]
机构：
[1] UAE Univ, Fac Med & Hlth Sci, Dept Pediat, Al Ain 9715, U Arab Emirates
来源：
PEDIATRICS | 2008年 / 122卷 / 03期
关键词：
D O I：
10.1542/peds.2008-1636
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：675 / 676
页数：8
相关论文
共 50 条
  • [41] An analysis of the cost-effectiveness of switching from biphasic human insulin 30, insulin glargine, or neutral protamine Hagedorn to biphasic insulin aspart 30 in people with type 2 diabetes
    Gupta, Vishal
    Baabbad, Ranya
    Hammerby, Eva
    Nikolajsen, Annie
    Shafie, Asrul Akmal
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (04) : 263 - 272
  • [42] The effects of subcutaneous neutral protamine Hagedorn (NPH) insulin on glucose metabolism following a period of insulin withdrawal in patients with Type 1 diabetes
    Herring, R.
    Shojaee-Moradie, F.
    Jackson, N.
    Jones, R.
    Umpleby, A. M.
    Russell-Jones, D. L.
    [J]. DIABETIC MEDICINE, 2013, 30 : 15 - 16
  • [43] Comparison of Incidence of Acute Myocardial Infarction in Patients With Type 2 Diabetes Mellitus Following Initiation of Neutral Protamine Hagedorn Insulin Versus Insulin Glargine (vol 104, pg 910, 2009)
    Rhoads
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (04): : 603 - 603
  • [44] A randomized trial comparing perinatal outcomes using insulin detemir or neutral protamine Hagedorn in type 1 diabetes
    Hod, Moshe
    Mathiesen, Elisabeth R.
    Jovanovic, Lois
    McCance, David R.
    Ivanisevic, Marina
    Duran-Garcia, Santiago
    Brondsted, Lise
    Nazeri, Avideh
    Damm, Peter
    [J]. JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2014, 27 (01): : 7 - 13
  • [45] Improved treatment satisfaction in patients with type 1 diabetes treated with insulin glargine 100 U/mL versus neutral protamine Hagedorn insulin: An exploration of key predictors from two randomized controlled trials
    Polonsky, William
    Traylor, Louise
    Gao, Ling
    Wei, Wenhui
    Ameer, Barbara
    Stuhr, Andreas
    Vlajnic, Aleksandra
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (03) : 562 - 568
  • [46] Replacement of neutral protamine Hagedorn insulin with the long-acting insulin analogue, detemir, improves glycemic control without weight gain in basal-bolus insulin therapy in Japanese patients with type 1 diabetes
    Hayakawa, Taro
    Ishii, Michiyo
    Watanabe, Megumi
    Iwase, Hiroya
    Nishimura, Asako
    Monden, Takako
    Kamiuchi, Kenji
    Isono, Motohide
    Shibata, Nobuhito
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2011, 2 (01) : 71 - 77
  • [47] Real-world outcomes of US employees with type 2 diabetes mellitus treated with insulin glargine or neutral protamine Hagedorn insulin: a comparative retrospective database study
    Wang, Li
    Wei, Wenhui
    Miao, Raymond
    Xie, Lin
    Baser, Onur
    [J]. BMJ OPEN, 2013, 3 (04):
  • [48] Will Long Acting Insulin Analogs Influence the Use of Insulin Pump Therapy in Type 1 Diabetes?
    DeVries, J. Hans
    [J]. CURRENT DIABETES REVIEWS, 2005, 1 (01) : 23 - 26
  • [49] Patient reported outcomes in adults with type 2 diabetes on basal insulin randomized to addition of mealtime pramlintide or rapid-acting insulin analogs
    Peyrot, Mark
    Rubin, Richard R.
    Polonsky, William H.
    Best, Jennie H.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (05) : 1047 - 1054
  • [50] A Rare Complication of Insulin Therapy in a Child with Newly Diagnosed Type 1 Diabetes: Insulin Edema
    Acar, Sezer
    Nalbantoglu, Ozlem
    Kirkgoz, Tarik
    Ozkaya, Beyhan
    Erkan, Omrum
    Ozkan, Behzat
    [J]. JOURNAL OF PEDIATRIC RESEARCH, 2021, 8 (04) : 506 - 509
12345